TL1A Antibody: Members in the TNF and its receptor superfamilies regulate immune responses and induce apoptosis. DR3 (also termed Wsl-1, Apo-3, TRAMP, and LARD) is preferentially expressed by T lymphocytes and upregulated during T cell activation. The ligand for DR3 was recently identified and designated TL1A. TL1A also binds decoy receptor DcR3/TR6, which is expressed in several lung and colon carcinomas and in some normal tissues. TL1A induces apoptosis and NF-κB activation in DR3 expressing cells, which is antagonized by DcR3. TL1A is upregulated by proinflammatory cytokines TNF and IL-1. TL1A is a longer variant of TL1 (also called VEGI).1) Chinnayan AM, O’Rourke K, Yu GL, et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996; 274:990-2.
Immunogen
TL1A antibody was raised against recombinant human TL1A.
Western blot analysis of TL1A in human placenta tissue lysate with TL1A antibody at 2 μg/mL.
Positive Control
1) Cat. No. 1309 - Human Placenta Tissue Lysate
Application Notes
WB:1:500~1:1000 ELISA:1:5000~20000
Additional Information
Form
Liquid
Storage Instructions
TL1A antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Storage Buffer
TL1A Antibody is supplied in PBS containing 0.02% sodium azide.